SCNI Stock Summary and Trading Ideas (Scinai Immunotherapeutics Ltd. - American Depositary Shares | NASDAQ:SCNI)

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

Scinai Immunotherapeutics Ltd. - American Depositary Shares trades on the NASDAQ stock market under the symbol SCNI.

As of January 15, 2026, SCNI stock price declined to $0.92 with 24,100 million shares trading.

SCNI has a beta of 1.47, meaning it tends to be more sensitive to market movements. SCNI has a correlation of 0.09 to the broad based SPY ETF.

SCNI has a market cap of $3.19 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that SCNI belongs to (by Net Assets): SPDW.

SCNI has underperformed the market in the last year with a return of -73.3%, while the SPY ETF gained +20.6%. In the last 3 month period, SCNI fell short of the market, returning -32.8%, while SPY returned +5.2%. However, in the most recent 2 weeks SCNI has outperformed the stock market by returning +29.2%, while SPY returned +1.9%.

SCNI support price is $.88 and resistance is $1.04 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SCNI shares will trade within this expected range on the day.